Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

10.73
Delayed Data
As of Feb 27
 -0.17 / -1.56%
Today’s Change
3.44
Today|||52-Week Range
11.68
+14.27%
Year-to-Date

Today’s Trading

Previous close10.90
Today’s open10.84
Day’s range10.72 - 11.00
Volume630,830
Average volume (3 months)508,429
Market cap$395.9M
Dividend yield--
Data as of 4:00pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-1,300.00%
Earnings growth (this year)-15.71%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+38.43%
P/E ratioNM
Price/Sales1.08
Price/Book3.47

Competitors

 Today’s
change
Today’s
% change
SPPISpectrum Pharmaceuti...+0.04+0.65%
DERMDermira Inc-1.17-6.54%
TKMRTekmira Pharmaceutic...-0.22-1.20%
PRTKParatek Pharmaceutic...-1.18-3.88%
Data as of 4:00pm ET, 02/27/2015

Financials

Next reporting dateMay 18, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$84.9M
Annual profit (last year)-$25.6M
Net profit margin-30.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account